Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

By | December 3, 2021
A recent study reports neutralizing efficacy for a fused peptide-antibody molecule against SARS-CoV-2, providing hope that therapeutic neutralizing antibodies may soon be available.